Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available ...

Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Evangelion's Hideaki Anno has revealed he's currently working on five different anime ...

Episode Nine, Act One June 25, 2024 Aug. 28, 2024 VALORANT console release, agent, mode, and map updates Episode Nine, Act Two Aug. 28, 2024 Oct. 23, 2024 New agent ...

This word has appeared in 77 articles on NYTimes.com in the past year. Can you use it in a sentence? By The Learning Network This word has appeared in 71 articles on NYTimes.com in the past year ...

Despite these challenges, Regeneron's other drugs, particularly Dupixent and Libtayo ... polyposis (2019), prurigo nodularis (2022), eosinophilic esophagitis (2022), and most recently, COPD ...

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

Dupixent has received regulatory approvals in more than 60 countries in one or more indications including certain patients with atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, ...